Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29282
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Poppel M.N.M.en
dc.contributor.authorThangaratinam S.en
dc.contributor.authorDunne F.P.en
dc.contributor.authorDevane D.en
dc.contributor.authorBiesty L.M.en
dc.contributor.authorCrowther C.en
dc.contributor.authorEgan A.M.en
dc.contributor.authorBogdanet D.en
dc.contributor.authorGriffin T.P.en
dc.contributor.authorKgosidialwa O.en
dc.contributor.authorCervar-Zivkovic M.en
dc.contributor.authorDempsey E.en
dc.contributor.authorAllotey J.en
dc.contributor.authorAlvarado F.en
dc.contributor.authorClarson C.en
dc.contributor.authorCooray S.D.en
dc.contributor.authorde Valk H.W.en
dc.contributor.authorGaljaard S.en
dc.contributor.authorLoeken M.R.en
dc.contributor.authorMaresh M.J.A.en
dc.contributor.authorNapoli A.en
dc.contributor.authorO'Shea P.M.en
dc.contributor.authorWender-Ozegowska E.en
dc.date.accessioned2021-05-14T09:53:25Zen
dc.date.available2021-05-14T09:53:25Zen
dc.date.copyright2020en
dc.date.created20200601en
dc.date.issued2020-06-01en
dc.identifier.citationDiabetologia. 63 (6) (pp 1120-1127), 2020. Date of Publication: 01 Jun 2020.en
dc.identifier.issn0012-186Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/29282en
dc.description.abstractAims/hypothesis: The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). Method(s): We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised. Result(s): Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). Conclusions/interpretation: This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. Trial registration: This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/studies/details/686/.Copyright © 2020, The Author(s).en
dc.languageEnglishen
dc.languageenen
dc.publisherSpringeren
dc.relation.ispartofDiabetologiaen
dc.subject.meshclinical effectiveness-
dc.subject.meshbirth-
dc.subject.meshbirth weight-
dc.subject.meshDelphi study-
dc.subject.meshgestational age-
dc.subject.meshgestational weight gain-
dc.subject.meshhyperglycemia-
dc.subject.meshhypoglycemia-
dc.subject.meshlarge for gestational age-
dc.subject.meshmaternal hypertension-
dc.subject.meshnewborn-
dc.subject.meshpatient compliance-
dc.subject.meshpregnancy diabetes mellitus-
dc.subject.meshpremature labor-
dc.subject.meshsmall for date infant-
dc.subject.meshstillbirth-
dc.subject.meshantidiabetic agent-
dc.titleA core outcome set for studies of gestational diabetes mellitus prevention and treatment.en
dc.typeArticleen
dc.identifier.affiliationDiabetes and Vascular Medicine-
dc.type.studyortrialSystematic review and/or meta-analysis-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00125-020-05123-6-
dc.publisher.placeGermanyen
dc.identifier.pubmedid32193573 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32193573]en
dc.identifier.source2004570311en
dc.identifier.institution(Egan) Division of Endocrinology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, United States (Bogdanet, Griffin, Kgosidialwa, O'Shea, Dunne) School of Medicine, National University of Ireland Galway, Galway, Ireland (Griffin) Department of Endocrinology, St Vincent's University Hospital, Dublin, Ireland (Cervar-Zivkovic) Division of Obstetrics, Medizinische Universitat Graz, Graz, Austria (Dempsey, Devane) INFANT Centre and Department of Paediatrics & Child Health, University College Cork, Cork, Ireland (Allotey, Cooray, Thangaratinam) Barts Research Centre for Women's Health (BARC), Women's Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Alvarado) Mother Infant Research Institute, Tufts Medical Center, Boston, MA, United States (Clarson) Department of Pediatrics, University of Western Ontario, London, ON, Canada (Clarson) Lawson Health Research Institute, London, ON, Canada (Cooray) Diabetes and Vascular Medicine Unit, Monash Health, Melbourne, VIC, Australia (Cooray) Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC, Australia (de Valk) Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, Netherlands (Galjaard) Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre Rotterdam, 's-Gravendijkwal 230, Rotterdam 3015 CE, Netherlands (Loeken) Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, United States (Loeken) Department of Medicine, Harvard Medical School, Boston, MA, United States (Maresh) Department of Obstetrics, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom (Napoli) Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza, University of Rome, Rome, Italy (Wender-Ozegowska) Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland (van Poppel) Institute of Sport Science, University of Graz, Graz, Austria (Thangaratinam) Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom (Crowther) Liggins Institute, The University of Auckland, Auckland, New Zealand (Biesty, Devane) School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland (Biesty, Devane) HRB-Trials Methodology Research Network, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Irelanden
dc.description.addressA.M. Egan, Division of Endocrinology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, United States. E-mail: egan.aoife@mayo.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordsClinical diabetes Core outcome set Insulin therapy Pregnancy Systematic reviewen
dc.identifier.authoremailEgan A.M.; egan.aoife@mayo.edu Galjaard S.; s.galjaard@erasmusmc.nlen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Articles
Show simple item record

Page view(s)

32
checked on Sep 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.